135 related articles for article (PubMed ID: 14659771)
1. Post menopausal hormone replacement therapy and risk of acute myocardial infarction--a case control study of women in the East Midlands, UK.
Chilvers CE; Knibb RC; Armstrong SJ; Woods KL; Logan RF
Eur Heart J; 2003 Dec; 24(24):2197-205. PubMed ID: 14659771
[TBL] [Abstract][Full Text] [Related]
2. Myocardial infarction risk and hormone replacement: differences between products.
de Vries CS; Bromley SE; Farmer RD
Maturitas; 2006 Feb; 53(3):343-50. PubMed ID: 16040209
[TBL] [Abstract][Full Text] [Related]
3. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy and incidence of acute myocardial infarction. A population-based nested case-control study.
Varas-Lorenzo C; García-Rodríguez LA; Perez-Gutthann S; Duque-Oliart A
Circulation; 2000 Jun; 101(22):2572-8. PubMed ID: 10840007
[TBL] [Abstract][Full Text] [Related]
5. Hormone replacement therapy and risk of nonfatal acute myocardial infarction in Italy.
Tavani A; Bertuzzi M; Gallus S; Negri E; La Vecchia C
J Clin Epidemiol; 2005 Jul; 58(7):747-50. PubMed ID: 15939229
[TBL] [Abstract][Full Text] [Related]
6. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women.
Psaty BM; Smith NL; Lemaitre RN; Vos HL; Heckbert SR; LaCroix AZ; Rosendaal FR
JAMA; 2001 Feb; 285(7):906-13. PubMed ID: 11180734
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy is associated with improved arterial physiology in healthy post-menopausal women.
McCrohon JA; Adams MR; McCredie RJ; Robinson J; Pike A; Abbey M; Keech AC; Celermajer DS
Clin Endocrinol (Oxf); 1996 Oct; 45(4):435-41. PubMed ID: 8959082
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and risk of acute myocardial infarction : a review of the literature.
Bromley SE; de Vries CS; Thomas D; Farmer RD
Drug Saf; 2005; 28(6):473-93. PubMed ID: 15924502
[TBL] [Abstract][Full Text] [Related]
9. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
10. Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study.
Bretler DM; Hansen PR; Abildstrøm SZ; Jørgensen CH; Sørensen R; Hansen ML; Schramm TK; Løkkegaard E; Torp-Pedersen C; Gislason GH
Br J Clin Pharmacol; 2011 Jan; 71(1):105-15. PubMed ID: 21143506
[TBL] [Abstract][Full Text] [Related]
11. Case-control study of increased mammographic breast density response to hormone replacement therapy.
Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
[TBL] [Abstract][Full Text] [Related]
12. Hormone replacement therapy and risk of glioma: a nationwide nested case-control study.
Andersen L; Friis S; Hallas J; Ravn P; Gaist D
Cancer Epidemiol; 2013 Dec; 37(6):876-80. PubMed ID: 24138870
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy increases the risk of cranial meningioma.
Andersen L; Friis S; Hallas J; Ravn P; Schrøder HD; Gaist D
Eur J Cancer; 2013 Oct; 49(15):3303-10. PubMed ID: 23800670
[TBL] [Abstract][Full Text] [Related]
14. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
Seed M; Sands RH; McLaren M; Kirk G; Darko D
Fam Pract; 2000 Dec; 17(6):497-507. PubMed ID: 11120722
[TBL] [Abstract][Full Text] [Related]
15. Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial.
Woodson K; Lanza E; Tangrea JA; Albert PS; Slattery M; Pinsky J; Caan B; Paskett E; Iber F; Kikendall JW; Lance P; Shike M; Weissfeld J; Schatzkin A
J Natl Cancer Inst; 2001 Dec; 93(23):1799-805. PubMed ID: 11734596
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and lung cancer risk: a case-control analysis.
Schabath MB; Wu X; Vassilopoulou-Sellin R; Vaporciyan AA; Spitz MR
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):113-23. PubMed ID: 14734459
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy and acute myocardial infarction: a large observational study exploring the influence of age.
Kim J; Evans S; Smeeth L; Pocock S
Int J Epidemiol; 2006 Jun; 35(3):731-8. PubMed ID: 16394112
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for first-time acute myocardial infarction patients in Trinidad.
Bahall M; Seemungal T; Legall G
BMC Public Health; 2018 Jan; 18(1):161. PubMed ID: 29351744
[TBL] [Abstract][Full Text] [Related]
19. Tibolone and endometrial cancer: a cohort and nested case-control study in the UK.
de Vries CS; Bromley SE; Thomas H; Farmer RD
Drug Saf; 2005; 28(3):241-9. PubMed ID: 15733028
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy among postmenopausal women presenting with acute myocardial infarction: insights from the GUSTO-III trial.
Tackett AH; Bailey AL; Foody JM; Miller JM; Apperson-Hansen C; Ohman EM; Hochman JS; Karnash SL; Califf RM; Topol EJ; Moliterno DJ
Am Heart J; 2010 Oct; 160(4):678-84. PubMed ID: 20934562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
